{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5c254927edaa95cf2906e186/5c635d6a42c396c550c6dd51?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Elixinol Global Limited (OTC: ELLXF) Fast growing revenues in CBD & Hemp consumer products","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/5c254927edaa95cf2906e186/1550077614572-ca6af037733bf70232965cdb5fb12c0e.jpeg?height=200","description":"<p>We caught up with Paul, at the airport, to discuss Elixinol’s progress in the CBD and hemp consumer products and foods markets, which has resulted in over AUD$14 million revenues and profits in Q2 2018.</p><p>Paul also talks about the company’s business strategy, and the plans for deploying a recent AUD$40 million capital raise, to expand global sales growth.</p>","author_name":"WallStreetReporter.com"}